New Key Statistics Module, Z-Score and F-Score
NAS:NTLA Key Ratios
Market Cap $ M | 2,287.52 |
Enterprise Value $ M | 1,479.07 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.10 |
Price/Sales | 57.55 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 36.00 |
EPS (TTM) $ | -5.41 |
Beneish M-Score | 8.79 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -28.30 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.87 |
EV-to-EBITDA | -2.92 |
PEG | -- |
Shares Outstanding M | 96.44 |
Net Margin (%) | -1,326.51 |
Operating Margin % | -1,420.51 |
Pre-tax Margin (%) | -1,326.51 |
Quick Ratio | 8.67 |
Current Ratio | 8.67 |
ROA % (ttm) | -35.35 |
ROE % (ttm) | -42.82 |
ROIC % (ttm) | -122.06 |
Dividend Yield % | -- |
Altman Z-Score | 3.28 |
NTLA Number of Guru Trades
NTLA Volume of Guru Trades
Gurus Latest Trades with NAS:NTLA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:NTLA is held by these investors
Total 1
Intellia Therapeutics Inc Insider Transactions
No Available Data
News about NAS:NTLA
Total 0- 1